Vifor Pharma has been acquired by CSL Behring and is now branded CSL Vifor. It aims to become the leader in iron deficiency, nephrology and cardio-renal therapies. The company strives to help patients around the world with severe and chronic diseases lead better, healthier lives.
Facts & figures
-
Type of organizationPublic company
-
Year of foundation1944
-
Number of employees in Switzerland>250
